Key Developments: CareFusion Corp (CFN.N)

CFN.N on New York Stock Exchange

56.34USD
17 Oct 2014
Price Change (% chg)

$0.01 (+0.02%)
Prev Close
$56.33
Open
$56.74
Day's High
$56.74
Day's Low
$56.34
Volume
1,023,532
Avg. Vol
512,316
52-wk High
$58.00
52-wk Low
$37.11

Search Stocks

Latest Key Developments (Source: Significant Developments)

Netsmart, Carefusion collaboration to bring medication management solutions to health and human services communities
Wednesday, 8 Oct 2014 04:53pm EDT 

CareFusion Corp:Says the company and Netsmart announced an agreement to bring enhanced medication dispensing and management capabilities to behavioral health care provider organizations nationwide.Says the two companies will collaborate to integrate the medication use expertise of CareFusion with the closed-loop medication management capabilities of Netsmart, while re-defining interoperability within the non-acute health care industry.Under the agreement, Netsmart, the knowledge and technology partner for health and human services, will provide selected CareFusion solutions, including the Pyxis MedStation ES system that offers safe, controlled and efficient dispensing of medications for patients in all care settings.  Full Article

CareFusion Corp gives FY 2015 guidance; revenue guidance below analysts' estimates; gives long term guidance
Thursday, 7 Aug 2014 04:08pm EDT 

CareFusion Corp:Expects FY 2015 revenue to grow 5 pct. to 7 pct. on constant currency basis compared to FY 2014 revenue of $3.84 bln.Expects FY 2015 adjusted diluted earnings per share (EPS) from continuing operations to be in range of $2.60 to $2.75.Provides its three-year outlook through FY 2017, with expectations for mid-single-digit revenue growth and compound annual growth rate for adjusted diluted earnings per share from continuing operations of 10 pct. to 12 pct.FY 2015 revenue of $4.04 bln and EPS of $2.68 - Thomson Reuters I/B/E/S.FY 2016 revenue of $4.17 bln and EPS of $2.90 - Thomson Reuters I/B/E/S.FY 2017 revenue of $4.36 bln and EPS of $3.31 - Thomson Reuters I/B/E/S.  Full Article

Carefusion Corp prices $1 billion of senior unsecured notes
Thursday, 15 May 2014 05:46pm EDT 

Carefusion Corp:Prices three series of senior unsecured notes for an aggregate principal amount of $1 bln.Of these notes, $300 mln will mature in 2017 and will bear interest at an annual rate of 1.450 percent.$400 mln will mature in 2024 and will bear interest at an annual rate of 3.875 percent and $300 mln will mature in 2044 and will bear interest at an annual rate of 4.875 percent.CareFusion intends to use portion of net proceeds from the offering to repay at maturity its $450 mln in aggregate outstanding principal amount of 5.125 percent senior notes due 2014.Company intends to use remaining net proceeds of offering for general corporate purposes.Offering is expected to close on May 22, 2014.Barclays Capital Inc., J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated are acting as joint book-running managers and representatives of the several underwriters.  Full Article

Carefusion Corp raises low end of prior FY 2014 revenue guidance to a range in line with analysts' estimates; Sees FY 2014 EPS guidance at low end of prior range
Monday, 5 May 2014 04:02pm EDT 

Carefusion Corp:Expects FY 2014 revenue as reported to grow 5 pct to 7 pct, an increase from the prior 4 pct to 7 pct range and organic revenue to grow 2 pct to 4 pct, up from the previous 1 pct to 4 pct range, both on a constant currency basis as compared to FY 2013 revenue of $3.55 billion.Says adjusted diluted earnings per share from continuing operations are now expected to be at the low end of the company's previously stated guidance range of $2.30 to $2.40.FY 2014 revenue of $3.76 billion and EPS of $2.34 - Thomson Reuters I/B/E/S.  Full Article

Carefusion Corp reaffirms FY 2014 guidance
Monday, 3 Feb 2014 04:02pm EST 

Carefusion Corp:Says for fiscal 2014 it continues to expect organic revenue to grow 1 pct. to 4 pct. on a constant currency basis compared to fiscal 2013 revenue of $3.55 billion.Sees fiscal 2014 adjusted diluted earnings per share (EPS) from continuing operations to be in the range of $2.30 to $2.40.Reported revenue of $3.550 billion in fiscal 2013.Fiscal 2014 revenue of $3.704 billion - Thomson Reuters I/B/E/S.Fiscal 2014 EPS of $2.34 -m Thomson Reuters I/B/E/S.  Full Article

Carefusion Corp, Terumo Corp signs distribution agreement for IV Catheters
Wednesday, 29 Jan 2014 08:30am EST 

Carefusion Corp and Terumo Corp:Says an exclusive, eight-year agreement for CareFusion to co-brand, market and distribute Terumo's SurFlash line of safety peripheral IV catheters for the acute care segment across the United States.Says the agreement includes both SurFlash and SurFlash Plus Safety IV Catheters, which are proven to improve the success of catheter placement on the first attempt by an average of 20 percent.  Full Article

Carefusion Corp completes vital signs acquisition in U.S., China
Tuesday, 31 Dec 2013 08:30am EST 

Carefusion Corp:Says the completion of its acquisition of the Vital Signs division from GE Healthcare in the U.S., China and certain other geographies.Says it agreed to purchase Vital Signs for $500 million.Says in connection with this first closing, CareFusion paid GE Healthcare approximately $470 million, funded through cash on hand.Says the balance of the purchase price will be paid upon completion of the acquisition of the remaining international operations of Vital Signs, pending regulatory review and customary closing conditions.  Full Article

Carefusion Corp To Buy General Electric Co's Respiratory, Anesthesiology Products Business - Reuters
Monday, 18 Nov 2013 08:19am EST 

Reuters reported that CareFusion Corp said it will buy General Electric Co's Healthcare's respiratory care and anesthesiology products business, Vital Signs, for $500 million.  Full Article

Carefusion Corp Reaffirms FY 2014 Guidance
Thursday, 7 Nov 2013 04:03pm EST 

Carefusion Corp announced that for fiscal 2014 continues to expect organic revenue to grow 1% to 4% on a constant currency basis compared to fiscal 2013 revenue of $3.55 billion. Adjusted diluted earnings per share from continuing operations are expected to be in the range of $2.30 to $2.40. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $3.63 billion, EPS of $2.11 for fiscal 2014.  Full Article

Carefusion Corp Announces Auditor Change-Form 8-K
Friday, 9 Aug 2013 04:45pm EDT 

Carefusion Corp reported in its Form 8-K that as previously disclosed by CareFusion Corporation (Company) in its Form 8-K filed May 29, 2013, the Audit Committee of the Board of Directors of the Company conducted a competitive process to determine the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2014 (Fiscal 2014). As a result of this process, the Committee approved the appointment of PricewaterhouseCoopers LLP (PwC) as the Company’s independent registered public accounting firm for Fiscal 2014. As reported in the Form 8-K filed May 29, 2013, the Committee dismissed Ernst &Young LLP (Ernst & Young) as the Company’s independent registered public accounting firm, effective upon the completion of its audit of the Company’s financial statements for the fiscal year ended June 30, 2013 (Fiscal 2013).  Full Article

Photo

Goldman leads $9.1 billion bridge loan for Becton Dickinson

NEW YORK - Medical equipment supplier Becton Dickinson & Co's acquisition of medical device manufacturer CareFusion will be financed with a $9.1 billion bridge loan, bankers said on Tuesday.

Search Stocks